Detalhe da pesquisa
1.
Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial.
Lancet Oncol
; 25(5): 649-657, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38608694
2.
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma.
Oncologist
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478923
3.
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med
; 384(9): 829-841, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33657295
4.
Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma.
J Urol
; : 101097JU0000000000003928, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573872
5.
Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events.
J Natl Compr Canc Netw
; : 1-8, 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190801
6.
Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry.
Endocr Pract
; 30(1): 25-30, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858722
7.
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
Oncologist
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38035767
8.
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors.
Am J Gastroenterol
; 118(9): 1609-1617, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307533
9.
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(7): 888-898, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688173
10.
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation.
BJU Int
; 129(5): 610-620, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228889
11.
Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial.
Lancet Oncol
; 22(12): 1732-1739, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34717797
12.
Outcomes of patients with intermediate-risk or poor-risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience.
Int J Cancer
; 149(2): 387-393, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739450
13.
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
Cancer
; 127(6): 840-849, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216356
14.
Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies.
Oncologist
; 26(6): 476-482, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792094
15.
The evolving treatment landscape of advanced urothelial carcinoma.
Curr Opin Oncol
; 33(3): 221-230, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33818541
16.
Association of Chronic Immune-Mediated Diarrhea and Colitis With Favorable Cancer Response.
J Natl Compr Canc Netw
; 19(6): 700-708, 2020 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33316767
17.
Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer.
Oncology (Williston Park)
; 33(1): 11-8, 2019 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30731013
18.
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.
BJU Int
; 120(6): 782-792, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27860149
19.
Non-clear cell renal cell carcinomas: biological insights and therapeutic challenges and opportunities.
Clin Adv Hematol Oncol
; 15(5): 409-418, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28591094
20.
Association of Emotional Exhaustion With Career Burnout Among Early-Career Medical Oncologists: A Single-Institution Study.
JCO Oncol Pract
; 20(1): 137-144, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37235818